Iodoacetamide

Iodoacetamide

SCHEMBL2218893

CCN(CC)c1cc2ccccc2oc1=O.NC(=O)CI

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 1/20 0.48
LMNA P02545 2/20 0.47
ALDH1A1 P00352 5/20 0.46
HPGD P15428 5/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
ATM Q13315 1/20 0.46
MAOB P27338 8/20 0.46
KDM4E B2RXH2 4/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CYP1A2 P05177 2/20 0.46
NT5E P21589 1/20 0.46
MAOA P21397 2/20 0.44
CA1 P00915 1/20 0.43
CA3 P07451 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145996 0.88 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
Thiourea SCHEMBL6715523 0.86 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL407381 0.81 MAOB (0.50) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL3933571 0.76 PGR (0.47) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL30241252 0.74 MAOB (0.54) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL28996736 0.74 MAOB (0.54) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL27715978 0.74 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL11425515 0.71 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL259563 0.71 HPGD (0.55) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL28180663 0.71 MEN1 (0.44) SMN1; SMN2NPC1RAB9ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120850-B2 Biosensor for detection and visualisation of single-stranded DNA MEDICAL RESEARCH COUNCIL (GB) 2015-09-01 US disclosed
EP-2170937-B1 LABELED SINGLE-STRAND DNA-BINDING PROTEIN AND ITS USE IN A BIOSENSOR FOR DETECTION AND VISUALISATION OF SINGLE-STRANDED DNA MEDICAL RES COUNCIL (GB) 2014-04-30 EP disclosed
US-20110177501-A1 BIOSENSOR FOR DETECTION AND VISUALISATION OF SINGLE-STRANDED DNA MEDICAL RESEARCH COUNCIL 2011-07-21 US disclosed
EP-2170937-A1 LABELED SINGLE-STRAND DNA-BINDING PROTEIN AND ITS USE IN A BIOSENSOR FOR DETECTION AND VISUALISATION OF SINGLE-STRANDED DNA Medical Research Council (GB) 2010-04-07 EP disclosed
WO-2008152379-A1 LABELED SINGLE-STRAND DNA-BINDING PROTEIN AND ITS USE IN A BIOSENSOR FOR DETECTION AND VISUALISATION OF SINGLE-STRANDED DNA MEDICAL RESEARCH COUNCIL (GB) 2008-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177501-A1 BIOSENSOR FOR DETECTION AND VISUALISATION OF SINGLE-STRANDED DNA SSBP1, SSB, DDB1 SMN1; SMN2 1593/4885NPC1 4651/4885RAB9A 3233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.